Duane A. Mitchell, M.D., Ph.D. is the University of Florida (UF) Assistant Vice President of Research and Associate Dean for Translational Science and Clinical Research at the UF College of Medicine. He serves as Director of the UF Clinical Translational Science Institute (CTSI) and Co-Director of the Preston A. Wells, Jr. Center for Brain Tumor Therapy. Dr. Mitchell is a leading expert in the development of innovative immunotherapy treatments for adults and children with malignant brain tumors. He has pioneered many novel brain tumor immunotherapy treatments that have been translated into first-in-human clinical trials and multi-center phase 2 studies. Dr. Mitchell has received numerous awards and recognition for his work, including a 2016 Top 10 Clinical Research Achievement Award from the Clinical Research Forum in Washington, D.C. Dr. Mitchell's research has been funded by the NIH, Department of Defense, and numerous private foundations. He serves on many national and international advisory boards for industry, academia, and government agencies including the NCI Board of Scientific Counselors, Cancer Prevention and Research Institute of Texas (CPRIT) Scientific Review Board, and gubernatorial appointee to the Scientific Advisory Board for the Florida Center for Brain Tumor Research (FCBTR). Dr. Mitchell lives with his wife of twenty years, Michelle Mitchell, and their three sons, Anthony, Brandon, and Austin, in Gainesville, Florida.